122 related articles for article (PubMed ID: 3069943)
21. Combined effect of 5-fluorouracil and carboplatin against human gastric cancer cell lines in vitro and in vivo.
Saikawa Y; Kubota T; Kuo TH; Tanino H; Kase S; Furukawa T; Watanabe M; Ishibiki K; Kitajima M; Hoffman RM
Anticancer Res; 1994; 14(2A):461-4. PubMed ID: 8017848
[TBL] [Abstract][Full Text] [Related]
22. Preclinical efficacy and pharmacokinetics of AP5346, a novel diaminocyclohexane-platinum tumor-targeting drug delivery system.
Rice JR; Gerberich JL; Nowotnik DP; Howell SB
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2248-54. PubMed ID: 16609041
[TBL] [Abstract][Full Text] [Related]
23. Potentiation of platinum antitumor effects in human lung tumor xenografts by the angiogenesis inhibitor squalamine: effects on tumor neovascularization.
Schiller JH; Bittner G
Clin Cancer Res; 1999 Dec; 5(12):4287-94. PubMed ID: 10632372
[TBL] [Abstract][Full Text] [Related]
24. [Therapeutic values of prostaglandin D2 in nude mice bearing human ovarian carcinoma].
Kikuchi Y; Miyauchi M; Nagata I
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Feb; 42(2):121-8. PubMed ID: 2313142
[TBL] [Abstract][Full Text] [Related]
25. [Effects of anticancer agents on 7, 12-dimethylbenz (a) anthracene induced rat ovarian cancer cell line (DMBA-OC-1) and human ovarian serous adenocarcinoma cell line (KOC-1S)].
Kataoka A; Yokota D; Sugiyama T; Oda T; Nishida T; Yakushiji M
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Oct; 41(10):1523-9. PubMed ID: 2511256
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetic correlation between experimental and clinical effects on human non-small cell lung cancers of cis-diammineglycolatoplatinum (254-S) and cis-diamminedichloroplatinum.
Koenuma M; Kasai H; Uchida N; Wada T; Hattori M; Oguma T; Totani T; Inaba M
Anticancer Res; 1995; 15(2):417-21. PubMed ID: 7763015
[TBL] [Abstract][Full Text] [Related]
27. Development of a panel of 15 human ovarian cancer xenografts for drug screening and determination of the role of the glutathione detoxification system.
Kolfschoten GM; Pinedo HM; Scheffer PG; Schlüper HM; Erkelens CA; Boven E
Gynecol Oncol; 2000 Mar; 76(3):362-8. PubMed ID: 10684711
[TBL] [Abstract][Full Text] [Related]
28. Complete inhibition of human ovarian cancer xenografts in nude mice by suramin and cis-diamminedichloroplatinum(II).
Kikuchi Y; Hirata J; Hisano A; Tode T; Kita T; Nagata I
Gynecol Oncol; 1995 Jul; 58(1):11-5. PubMed ID: 7789875
[TBL] [Abstract][Full Text] [Related]
29. [Anti-cancer drug sensitivity test against human testicular cancer xenograft--comparison with clinical results of chemotherapy].
Miki T; Kotake T
Hinyokika Kiyo; 1988 Nov; 34(11):1903-9. PubMed ID: 3242364
[TBL] [Abstract][Full Text] [Related]
30. [Combination chemotherapy of paclitaxel followed by nedaplatin for human ovarian cancer].
Uchida N; Yamada H; Maekawa R; Yoshioka T
Gan To Kagaku Ryoho; 2002 Nov; 29(11):1943-9. PubMed ID: 12465394
[TBL] [Abstract][Full Text] [Related]
31. Batimastat, a synthetic inhibitor of matrix metalloproteinases, potentiates the antitumor activity of cisplatin in ovarian carcinoma xenografts.
Giavazzi R; Garofalo A; Ferri C; Lucchini V; Bone EA; Chiari S; Brown PD; Nicoletti MI; Taraboletti G
Clin Cancer Res; 1998 Apr; 4(4):985-92. PubMed ID: 9563894
[TBL] [Abstract][Full Text] [Related]
32. In vitro antitumor activity of a new platinum complex, DWA2114R against human tumor cell lines.
Akamatsu K; Saito H; Tsunenari T; Matsumoto T; Morikawa K; Koizumi M; Mitsui H; Koizumi K
Anticancer Res; 1993; 13(6A):2261-5. PubMed ID: 8297143
[TBL] [Abstract][Full Text] [Related]
33. [Development of carboplatin].
Tsukagoshi S
Gan To Kagaku Ryoho; 1990 Sep; 17(9):1949-58. PubMed ID: 2203318
[TBL] [Abstract][Full Text] [Related]
34. In vivo studies of adenovirus-mediated p53 gene therapy for cis-platinum-resistant human ovarian tumor xenografts.
Song K; Cowan KH; Sinha BK
Oncol Res; 1999; 11(3):153-9. PubMed ID: 10527075
[TBL] [Abstract][Full Text] [Related]
35. Antitumor activity of new organometallic compounds in human ovarian cancer cell lines and comparison to platin derivatives.
Moebus VJ; Stein R; Kieback DG; Runnebaum IB; Sass G; Kreienberg R
Anticancer Res; 1997; 17(2A):815-21. PubMed ID: 9137413
[TBL] [Abstract][Full Text] [Related]
36. Chemosensitivity testing of a novel platinum analog, nedaplatin (254-S), in human gynecological carcinomas: a comparison with cisplatin.
Koshiyama M; Kinezaki M; Uchida T; Sumitomo M
Anticancer Res; 2005; 25(6C):4499-502. PubMed ID: 16334133
[TBL] [Abstract][Full Text] [Related]
37. Preclinical antitumor activity of orally administered platinum (IV) complexes.
Rose WC; Crosswell AR; Schurig JE; Casazza AM
Cancer Chemother Pharmacol; 1993; 32(3):197-203. PubMed ID: 8500224
[TBL] [Abstract][Full Text] [Related]
38. [Antitumor effect of carboplatin and iproplatin on human urinary bladder and prostatic cancers grown in nude mice].
Hasegawa J; Kawamura N; Yamada S; Tsuboi N; Akimoto M
Gan To Kagaku Ryoho; 1987 Dec; 14(12):3279-83. PubMed ID: 3318705
[TBL] [Abstract][Full Text] [Related]
39. [Antitumor effects of high-dose cisplatin in hypertonic saline against human ovarian tumors heterotransplanted in nude mice].
Sawada M; Ozaki M; Hongo J; Hirota Y; Inagaki M; Koizumi K; Okamoto E
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jul; 39(7):1103-7. PubMed ID: 3611881
[TBL] [Abstract][Full Text] [Related]
40. [Assessment of the establishing individual protocol for effective chemotherapy of ovarian cancer--fundamental research using human tumor-nude mouse system].
Sawada M; Ozaki M; Hongo J; Hirota Y; Inagaki M
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Oct; 39(10):1776-83. PubMed ID: 3429976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]